Search Results - "Kok, RJ"

Refine Results
  1. 1

    Glomerular and tubular induction of the transcription factor c-Jun in human renal disease by De Borst, MH, Prakash, J, Melenhorst, WBWH, van den Heuvel, MC, Kok, RJ, Navis, G, van Goor, H

    Published in The Journal of pathology (01-10-2007)
    “…The transcription factor c-Jun regulates the expression of genes involved in proliferation and inflammation in many cell types but its role in human renal…”
    Get full text
    Journal Article
  2. 2

    RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature by Temming, Kai, Schiffelers, Raymond M., Molema, Grietje, Kok, Robbert J.

    Published in Drug resistance updates (01-12-2005)
    “…During the past decade, RGD-peptides have become a popular tool for the targeting of drugs and imaging agents to α vβ 3-integrin expressing tumour vasculature…”
    Get full text
    Journal Article
  3. 3

    Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment by Alaarg, Amr, Jordan, Nan Yeun, Verhoef, Johan Jf, Metselaar, Josbert M, Storm, Gert, Kok, Robbert J

    Published in International journal of nanomedicine (01-01-2016)
    “…Inflammation, oxidative stress, and uncontrolled cell proliferation are common key features of chronic inflammatory diseases, such as atherosclerosis and…”
    Get full text
    Journal Article
  4. 4

    The influence of forward-scattered light in transmission measurements of (exo)planetary atmospheres by de Kok, R.J., Stam, D.M.

    Published in Icarus (New York, N.Y. 1962) (01-11-2012)
    “…► We simulate atmospheric transmission measurements with a Monte Carlo model. ► Forward-scattered light can change exoplanet transit depths significantly. ►…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin by Schiffelers, Raymond M, Koning, Gerben A, ten Hagen, Timo L.M, Fens, Marcel H.A.M, Schraa, Astrid J, Janssen, Adriënne P.C.A, Kok, Robbert J, Molema, Grietje, Storm, Gert

    Published in Journal of controlled release (28-08-2003)
    “…Angiogenesis is a key process in the growth and metastasis of a tumor. Disrupting this process is considered a promising treatment strategy. Therefore, a drug…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo by Ogawara, Ken-ichi, Rots, Marianne G, Kok, Robbert J, Moorlag, Henk E, Van Loenen, Anne-Miek, Meijer, Dirk K F, Haisma, Hidde J, Molema, Grietje

    Published in Human gene therapy (01-05-2004)
    “…To assess the possibilities of retargeting adenovirus to activated endothelial cells, we conjugated bifunctional polyethylene glycol (PEG) onto the adenoviral…”
    Get more information
    Journal Article
  8. 8

    Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics by Kok, Robbert J, Schraa, Astrid J, Bos, Erwin J, Moorlag, Henk E, Asgeirsdóttir, Sigridur A, Everts, Maaike, Meijer, Dirk K F, Molema, Grietje

    Published in Bioconjugate chemistry (01-01-2002)
    “…Tumor blood vessels can be selectively targeted by RGD-peptides that bind to alpha(v)beta(3) integrin on angiogenic endothelial cells. By inhibiting the…”
    Get full text
    Journal Article
  9. 9

    Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells by Dolman, M E M, Harmsen, Stefan, Pieters, Ebel H E, Sparidans, Rolf W, Lacombe, Marie, Szokol, Bálint, Orfi, László, Kéri, György, Storm, Gert, Hennink, Wim E, Kok, Robbert J

    Published in International journal of nanomedicine (01-01-2012)
    “…Activated proximal tubular cells play an important role in renal fibrosis. We investigated whether sunitinib and a kidney-targeted conjugate of sunitinib were…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell by Greupink, Rick, Bakker, Hester I., Reker-Smit, Catharina, van Loenen-Weemaes, Anne-miek, Kok, Robbert-Jan, Meijer, Dirk K.F., Beljaars, Leonie, Poelstra, Klaas

    Published in Journal of hepatology (01-11-2005)
    “…Hepatic stellate cell (HSC) activation and proliferation are key events in the pathology of liver fibrosis. Inhibiting these parameters, therefore, is a…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Peptide-targeted PEG-liposomes in anti-angiogenic therapy by Janssen, A.P.C.A, Schiffelers, R.M, ten Hagen, T.L.M, Koning, G.A, Schraa, A.J, Kok, R.J, Storm, G, Molema, G

    Published in International journal of pharmaceutics (18-03-2003)
    “…Peptides with the RGD amino acid sequence show affinity for the alpha(v)beta(3) integrin, an integrin which is over-expressed on angiogenic endothelium and…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study by Schraa, Astrid J., Kok, Robbert J., Moorlag, Henk E., Bos, Erwin J., Proost, Johannes H., Meijer, Dirk K.F., de Leij, Lou F.M.H., Molema, Grietje

    Published in International journal of cancer (10-12-2002)
    “…Angiogenesis‐associated integrin αvβ3 represents an attractive target for therapeutic intervention because it becomes highly upregulated on angiogenic…”
    Get full text
    Journal Article
  15. 15

    Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate by Everts, Maaike, Kok, Robbert J, Asgeirsdottir, Sigridur A, Melgert, Barbro N, Moolenaar, Tom J. M, Koning, Gerben A, van Luyn, Marja J. A, Meijer, Dirk K. F, Molema, Grietje

    Published in The Journal of immunology (1950) (15-01-2002)
    “…In chronic inflammatory diseases, the endothelium is an attractive target for pharmacological intervention because it plays an important role in leukocyte…”
    Get full text
    Journal Article
  16. 16

    Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting by Schraa, Astrid J, Kok, Robbert J, Berendsen, Agnes D, Moorlag, Henk E, Bos, Erwin J, Meijer, Dirk K.F, de Leij, Lou F.M.H, Molema, Grietje

    Published in Journal of controlled release (04-10-2002)
    “…Tumor vasculature can be targeted by peptides containing an RGD (Arg–Gly–Asp) sequence, which bind to α vβ 3 and α vβ 5 integrins on angiogenic endothelial…”
    Get full text
    Journal Article
  17. 17

    RENAL-SELECTIVE DELIVERY AND ANGIOTENSIN-CONVERTING ENZYME INHIBITION BY SUBCUTANEOUSLY ADMINISTERED CAPTOPRIL-LYSOZYME by PRAKASH, Jai, VAN LOENEN-WEEMAES, Annemiek M, HAAS, Marijke, PROOST, Johannes H, MEIJER, Dirk K. F, MOOLENAAR, Frits, POELSTRA, Klaas, KOK, Robbert J

    Published in Drug metabolism and disposition (01-05-2005)
    “…In previous studies, we have demonstrated that the low molecular weight protein lysozyme can be used as a renal-selective drug carrier for delivery of the…”
    Get full text
    Journal Article
  18. 18

    Delivery of pharmacologically active dexamethasone into activated endothelial cells by dexamethasone–anti-E-selectin immunoconjugate by Ásgeirsdóttir, Sigridur A., Kok, Robbert J., Everts, Maaike, Meijer, Dirk K.F., Molema, Grietje

    Published in Biochemical pharmacology (15-05-2003)
    “…To deliver selectively anti-inflammatory agents into activated endothelial cells, drug-targeting conjugates were developed. Dexamethasone (Dexa) was covalently…”
    Get full text
    Journal Article
  19. 19

    Cellular handling of a dexamethasone-anti-E-selectin immunoconjugate by activated endothelial cells: Comparison with free dexamethasone by KOK, Robbert J, EVERTS, Maaike, ASGEIRSDOTTIR, Sigridur A, MEIJER, Dirk K. F, MOLEMA, Grietje

    Published in Pharmaceutical research (01-11-2002)
    “…For selective inhibition of endothelial cell activation in chronic inflammation, we have developed a dexamethasone-anti-E-selectin immunoconjugate. The present…”
    Get full text
    Journal Article
  20. 20

    Bioanalysis and pharmacokinetics of the p38 MAPkinase inhibitor SB202190 in rats by Prakash, Jai, Saluja, Vinay, Visser, Jan, Moolenaar, Frits, Meijer, Dirk K.F., Poelstra, Klaas, Kok, Robbert J.

    “…We have developed a sensitive and reproducible high performance liquid chromatography (HPLC)-UV method for the quantification of the p38 MAPkinase inhibitor…”
    Get full text
    Journal Article